Oman’s healthcare sector is witnessing a rapid transition toward advanced urological interventions, driven by the expansion of facilities like the Royal Hospital and various private medical centers. The demand for Nitinol Stone Extractors—critical for ureteroscopic stone removal—has surged as hospitals shift from invasive surgery to RIRS (Retrograde Intrarenal Surgery). ZRH Med, as a specialized manufacturer, bridges this gap by providing high-quality, biocompatible nitinol devices that ensure superior deflection and durability.
Our Nitinol Stone Extractors are designed for complex stone geometries, offering memory-shape retention that provides surgeons with unmatched reliability. Beyond the product, ZRH Med offers comprehensive localized support and compliance guidance, ensuring our devices meet the rigorous standards set by the Oman Ministry of Health.
The global trend towards digitally integrated endoscopy means that stone extractors must now pair seamlessly with high-definition digital ureteroscopes. We are currently evolving our design philosophy to include "Smart-Tip" technology, reducing the procedural trauma and increasing the Stone Free Rate (SFR) in even the most complex lithotripsy cases.
Q: Can ZRH Med support clinical trials in Oman?
A: We provide high-quality samples and all necessary technical dossiers for clinical evaluation by medical boards.
Q: What is the delivery timeline for the Oman market?
A: We optimize our supply chain for efficient air/sea freight to Muscat and Salalah to ensure minimal disruption to hospital
operations.
